April 28, 2026 Electroencephalography During Acute Painful Procedures in Neonates: a Scoping Review Although electroencephalography (EEG) is used to assess neonatal pain in research settings...
April 8, 2026 Webinar Recording Available: Scalable Approaches to Patient-Centered Benefit–Risk: Defining Patient-Focused Drug Development in Precision Medicine As precision medicine advances, approaches to benefit–risk must evolve beyond traditional models designed...
April 1, 2026 Advancing Rare Disease Innovation Through Responsible Data Sharing — Key Takeaways from the RISE Together: Data Sharing Across the Rare Disease Ecosystem At a recent public workshop co-convened by the Duke-Margolis Institute for Health Policy...
March 26, 2026 BioCentury Article: Critical Path Institute Aims to Bring Scale to Individualized Medicines FDA’s plausible mechanism framework aims to accelerate and expand drug development for patients...
March 12, 2026 The Critical Path Institute Podcast: Connecting the Dots Between T1D and CKD, from the Patient Perspective The newest Critical Path Institute® (C-Path) podcast episode features a candid and inspiring conversation...
February 16, 2026 Epilepsy disease classification: a community effort to enhance the Mondo Disease Ontology Epilepsy is a diverse group of neurological disorders affecting over 50 million people worldwide.
February 28, 2026 The Critical Path Institute Podcast: Connecting the Dots in Rare and Pediatric Diseases with VP Collin Hovinga In this episode of the Critical Path Institute© Podcast, C-Path VP of Rare/Orphan and Pediatric Disease Programs Collin...
March 19, 2026 Meeting Patients Where They Are: Validating Remote Digital Tools for Multi-Indication NMD Research The C-Path team is pleased to invite you to an upcoming webinar to discuss the scientific...
February 26, 2026 Amidst Rare Disease Awareness Month, C-Path Shines a Light on Listening As a Form of Precision Medicine This perspective builds on insights shared during C-Path’s Global Impact Conference 2025 panel, “Ensuring a Focus on...”
February 20, 2026 What Collaboration Makes Possible On a Tuesday afternoon in the fall of 2019, a biostatistician from a pharmaceutical company...
